CannLabs, Inc.
CannLabs, Inc. (CANL) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
canl · pe ratio · data through Dec 31, 2022
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for CannLabs, Inc. (CANL) measures how much investors pay for each dollar of the company's trailing earnings. CANL's current PE ratio of 0.09x is calculated by dividing its stock price of $0.00 by its TTM earnings per share of $0.00. −99.6% discount vs 5Y avg 23.8x
Source: FMP · /ratios-ttm · /analyst-estimates · 2022-12-31
PE Ratio History
2009 – 2022 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 4 fiscal years · Front-end computedMinQ1 · 25%22.6x
MedianQ3 · 75%46.3x
Max
At 0.09x, CANL's current P/E is lower than in 0% of its annual fiscal year readings over the past 4 years — historically low.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Drug Manufacturers - Specialty & Generic · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
CannLabs, Inc.You CANL | $0M | 0.09x | — | $0.00 |
 Advantis Corp. ADVT | $0M | N/A | — | -$0.00 |
 Black Bird Biotech, Inc. BBBT | $0M | N/A | — | -$0.01 |
 Parallel Industries Inc. EAPH | $0M | N/A | — | -$0.00 |
 The Greater Cannabis Company, Inc. GCAN | $0M | N/A | — | -$0.00 |
 Green Rain Energy Holdings Inc. GREH | $0M | N/A | — | -$0.00 |
 Item 9 Labs Corp. INLB | $0M | N/A | — | -$0.33 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2022-12-31Latest FY2022 | 7.48x | $0.00 | -80.1% | |
2021-12-31 FY2021 | 37.65x | $0.00 | -18.6% | |
2020-12-31 FY2020 | 46.27x | $0.00 | +1091.4% | |
2019-12-31 FY2019 | 3.88x | $0.01 | — | |
2018-12-31 FY2018 | — | $-0.03 | — | |
2017-12-31 FY2017 | — | $-0.03 | — | |
2016-12-31 FY2016 | — | $-0.03 | — | |
2014-12-31 FY2014 | — | $-0.03 | — | |
2013-12-31 FY2013 | — | $-0.00 | — | |
2012-12-31 FY2012 | — | $-0.00 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for CannLabs, Inc. (CANL) measures how much investors pay for each dollar of the company's trailing earnings. CANL's current PE ratio of 0.09x is calculated by dividing its stock price of $0.00 by its TTM earnings per share of $0.00.
Frequently asked questions
CANL pe ratio · 6 questionsCANL's current PE ratio is 0.09x as of 2026-06-09, based on a stock price of $0.00 and TTM EPS of $0.00. Data sourced from Financial Modeling Prep via CANL's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · CannLabs, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09